Beyond randomized controlled trials

The efficacy of mammographic screening in the reduction of breast carcinoma mortality has been demonstrated in randomized controlled trials. However, the evaluation of organized screening outside of research settings (so‐called “service screening“) faces unique methodologic and conceptual challenges. The current study describes the evaluation of organized mammography screening in a clinical setting and demonstrates the benefit obtained from service screening in two Swedish counties.

[1]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[2]  I. Russell.  Breast screening , 1985, The Medical journal of Australia.

[3]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[4]  N. Day,et al.  Breast cancer screening programmes: the development of a monitoring and evaluation system. , 1989, British Journal of Cancer.

[5]  L. Tabár,et al.  Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.

[6]  S. Wall,et al.  Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.

[7]  L. Skoog,et al.  The general mammography screening program in Stockholm. Organisation and first-round results. , 1994, Acta oncologica.

[8]  L. Tabár,et al.  Efficacy of breast cancer screening by age. New results swedish two‐county trial , 1995, Cancer.

[9]  Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment? , 1997 .

[10]  R. Hendrick,et al.  Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. , 1997, Journal of the National Cancer Institute. Monographs.

[11]  D. Stockton,et al.  Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment? , 1997, BMJ.

[12]  N. Day,et al.  Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis , 1998, Journal of medical screening.

[13]  Criticisms of Swedish mammography trials were wrong [letter; comment] , 1999 .

[14]  J. Hendriks,et al.  Interval cancers in the Dutch breast cancer screening programme , 1999, British Journal of Cancer.

[15]  Breast screening , 1999, BMJ.

[16]  Criticisms of Swedish mammography trials were wrong , 1999, BMJ.

[17]  G. Sjönell,et al.  [Mammographic screening does not reduce breast cancer mortality]. , 1999, Lakartidningen.

[18]  Göran Sjönell,et al.  Scientific foundation of mammographic screening is based on inconclusive research in Sweden , 1999, BMJ.

[19]  P. J. van der Maas,et al.  Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom , 1999, Journal of medical screening.

[20]  HALSOKONTROLLER MED MAMMOGRAFI MINSKAR INTE DODLIGHET I BROSTCANCER , 1999 .

[21]  P. Dean,et al.  Screening mammography in Finland--1.5 million examinations with 97 percent specificity. Mammography Working Group, Radiological Society of Finland. , 1999, Acta oncologica.

[22]  R. Blanks,et al.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.

[23]  L. Nyström.  Screening mammography re-evaluated , 2000, The Lancet.

[24]  L. Tabár,et al.  A new era in the diagnosis of breast cancer. , 2000, Surgical oncology clinics of North America.

[25]  L. Tabár,et al.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.

[26]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[27]  S. Wingren,et al.  Incidence and prognosis in early onset breast cancer. , 2002, Breast.